Literature DB >> 4764610

Prognosis of myelomatosis on treatment with prednisone and cytostatics.

O P Hansen, B Jessen, A Videbaek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4764610     DOI： 10.1111/j.1600-0609.1973.tb00073.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN： 0036-553X


× No keyword cloud information.
  5 in total

1.  Late relapse in IgD myeloma: value of immunohistochemistry in trephine biopsy specimens.

Authors:  P Kettle; T C Morris
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

2.  Renal plasma clearance: a valuable marker in myelomatosis.

Authors:  O P Hansen; A Drivsholm
Journal:  Blut       Date:  1982-07

3.  [Analysis of prognostic factors in plasmacytoma].

Authors:  W Gassmann; T Haferlach; N Schmitz; W Kayser; H H Euler; J Drews; H Löffler
Journal:  Klin Wochenschr       Date:  1984-10-01

4.  Prognostic factors and classification in multiple myeloma.

Authors:  J F San Miguel; J Sànchez; M Gonzalez
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

Review 5.  Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Authors:  Gregory Fouquet; Ingrid Marcq; Véronique Debuysscher; Jagadeesh Bayry; Amrathlal Rabbind Singh; Abderrahmane Bengrine; Eric Nguyen-Khac; Mickael Naassila; Hicham Bouhlal
Journal:  Oncotarget       Date:  2018-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.